ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658371; 2) Community: the network communities that were significantly associated with the response to NSC 658371; 3) Molecule: the relationships between components within communities and NSC 658371; 4) MDR: the compounds that were significantly associated with the NSC 658371.

NSC Compound Enrichment Correlation
NSC 747558 6-(4-Ethylphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one 0.0244632509325736 0.28160133
NSC 750335 (E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0244632509325736 0.089405059
NSC 750441 Null 0.0244632509325736 0.24413156
NSC 750743 (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0244632509325736 0.26433285
NSC 754081 7-(4-methoxybenzyl)-4,4-dimethyl-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole 0.0244632509325736 0.20628188
NSC 755423 Null 0.0244632509325736 0.55567283
NSC 83492 Null 0.0244632509325736 0.29303004
NSC 96541 Benzo[f]quinoline-3-carbonitrile, 4-benzoyl-3,4-dihydro- (8CI9CI) 0.0244632509325736 0.40557946
NSC 681645 Camptothecin Derivative 0.0283958753782624 0.19153635
NSC 683558 Camptothecin Derivative 0.0283958753782624 0.16350368
Total:166  Current:113    [First] [Prev] [Next] [Last]